血尿治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004601
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 215
Buy Now

血尿治疗市场预计将从 2021 年的 9.3289 亿美元增至 2028 年的 11.0361 亿美元;预计 2021 年至 2028 年复合年增长率为 2.4%。

血尿是一种以尿液中出现血液为标志的疾病;正常情况下,尿液中不含红细胞。这可能会导致严重的问题,还可能导致肾结石、尿路感染和其他遗传性疾病。血尿相关适应症的高患病率、对治疗方案的认识不断提高以及医疗保健支出的改善等因素正在推动市场发展。然而,妨碍治疗有效性的相关适应症的未确诊病例阻碍了血尿治疗市场的增长。此外,相关治疗范围的扩大预计将为血尿治疗市场参与者提供巨大的增长机会,以扩大其客户群,特别是在发展中国家。

战略见解

< 2020 年,欧洲的 COVID-19 病例数量呈指数级增长。西班牙、德国、法国、意大利和英国是该地区受影响最严重的国家。据报道,COVID-19 患者中蛋白尿和血尿的患病率高于 AKI 患者。中国的回顾性研究报告称,在 COVID-19 患者中观察到蛋白尿和血尿,并且这些情况也与较高的死亡率相关。根据 2020 年 3 月建立的欧洲肾脏协会 (ERACODA) 的 COVID-19 数据库,约 25% 的肾移植患者被诊断患有 SARS-CoV-2。因此,新冠病毒阳性患者也更有可能接受肾脏疾病治疗。

血尿治疗市场利润丰厚的区域


< h3>市场洞察

血尿相关适应症的高患病率推动了血尿治疗市场的增长

慢性肾病 (CKD) 是一种常见且危及生命的疾病,影响着全球更多人口。 CKD 有多种类型,如肾结石、肾小球肾炎、多囊肾和尿路感染。 CKD 是血尿流行的主要原因之一。例如,根据美国国家生物技术信息中心 2019 年 5 月发表的一项研究,尿路感染 (UTI) 在美国通常被观察为门诊感染,主要发生在 14 至 24 岁年龄段的女性中。此外,65岁以上女性的尿路感染患病率约为20%,而总人口的患病率约为11%。目前,全球血尿治疗市场因相关适应症的患病率不断增加而显着增长。在北美,美国是血尿治疗市场的最大市场。该市场的增长主要是由于慢性肾脏病(CKD)患病率的增加以及主要参与者推出的产品数量不断增加而推动的。例如,2016 年,美国疾病控制与预防中心 (CDC) 表示,美国估计有 70 万人因终末期肾病 (ESRD) 接受治疗。1990 年至 2016 年间,ESRD 患病率增加了一倍多。 、成人血尿发病率的增加、意识的激增、广泛的研究和治疗开发活动预计还将推动血尿治疗的普及,这最终将为市场的增长提供利润丰厚的机会。老年人口的增加也是该市场的主要驱动力之一,因为老龄化是导致肾脏疾病发病率上升的突出风险因素。例如,根据人口资料局 2020 年发布的一项研究,到 2060 年,美国 65 岁的人口预计将增加一倍。

基于治疗见解

血尿治疗市场根据治疗方法分为药物、疗法等。由于血尿与尿路感染、肾结石、血癌、膀胱结石、前列腺癌等多种适应症有关,因此用于这些适应症的药物也可用于其治疗。阿夫唑嗪、环丙沙星、多沙唑嗪、布洛芬和坦索罗辛是治疗血尿的常用药物。这是一种优选的治疗类型,因为药物可以在家中和医疗机构中施用。

血尿治疗市场(按治疗方式) 2020 年和 2028 年


基于适应症的见解

基于适应症的血尿治疗市场,分为肾结石、尿路感染(UTI)、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎、外伤、剧烈运动、多囊肾病、子宫内膜异位症和月经。 2021年,尿路感染领域可能会占据最大的市场份额。此外,预计尿道炎血尿治疗市场在 2021 年至 2028 年期间的复合年增长率将达到 3.1%。

基于类型的洞察

血尿治疗市场根据类型分为肉眼血尿、镜下血尿、特发性血尿和慢跑者血尿。肉眼血尿细分市场可能会在 2021 年占据最大的市场份额。然而,预计微观血尿细分市场在预测期内的复合年增长率最高。

 

基于最终用户的见解

血尿治疗市场根据最终用户分为医院、诊所、门诊手术中心 (ASC) 等。 2021年,医院领域预计将占据最大的市场份额。此外,预计 2021 年至 2028 年诊所领域的需求将以最快的复合年增长率增长,达到 6.9%。

血尿治疗市场的公司采用治疗创新战略旨在满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌声誉。

血尿治疗市场 –按治疗

  • 药物
  • 疗法
  • 其他

血尿治疗市场 –按适应症

  • 尿路感染
  • 肾结石
  • 尿道炎
  • 血癌
  • 膀胱结石
  • 前列腺癌症
  • 膀胱炎、外伤
  • 剧烈运动
  • 多囊肾疾病
  • 子宫内膜异位症
  • 月经

血尿治疗市场按类型

  • 肉眼血尿
  • 微观血尿
  • 特发性血尿
  • 慢跑者血尿

血尿治疗市场 -按最终用户列出

  • 医院
  • 诊所
  • ASC
  • 其他

血尿治疗市场&nd;按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA其他地区
  • 南美洲和中美洲(SCAM )
    • 巴西
    • 阿根廷
    • 其余骗局

 
公司简介

  • 阿斯利康
  • 百时美施贵宝公司
  • F. HOFFMANN-LA ROCHE LTD。
  • 葛兰素史克公司。
  • 杨森制药
  • 默克公司。有限公司
  • 诺华公司
  • 辉瑞公司
  • Sun Pharmaceutical Industries Ltd
  • 勃林格殷格翰国际有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is hematuria treatment?

Hematuria is the presence of blood in the urine. Gross or visible hematuria occurs when the urine is red or pink, indicating the presence of blood in the urine. Blood can sometimes be found in the urine but is difficult to see; this is known as microscopic hematuria since it can only be seen under a microscope. The need for hematuria treatment has increased as the incidence of chronic renal disease and urinary tract infections has increased. Many tests, such as screening for sugar (diabetes), germs (infection), and blood, are performed on a regular basis. Blood can be detected with a chemical strip (also known as a dipstick) or under a microscope.

What are the driving factors for the hematuria treatments market across the globe?

Key factors that are driving the growth of this market are high prevalence of hematuria-associated indications and increasing awareness about treatment options and improving healthcare expenditure are expected to boost the market growth for the hematuria treatments over the years.

What is the market CAGR value of hematuria treatments market during forecast period?

The CAGR value of the hematuria treatments market during the forecasted period of 2021-2028 is 2.4%.

Which treatment type led the hematuria treatments market?

The drugs segment held the largest share of the market in the global hematuria treatments market and held the largest market share of 56.99% in 2020.

Which indication held the largest share in the hematuria treatments market?

The urinary tract infections segment dominated the global hematuria treatments market and accounted for the largest market share of 17.31% in 2020.

Which type held the largest share in the hematuria treatments market?

The macroscopic hematuria segment dominated the global hematuria treatments market and held the largest market share of 48.04% in 2020.

Which end-user held the largest share in the hematuria treatments market?

The hospitals segment dominated the global hematuria treatments market and held the largest market share of 36.52% in 2020.

Who are the key players in the hematuria treatments market?

The hematuria treatments market majorly consists of the players such AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH among others.

The List of Companies - Hematuria Treatment Market

  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports